{
    "Trade/Device Name(s)": [
        "Dimension Vista\u2122 PBNP reagent cartridge",
        "Dimension Vista\u2122 PBNP calibrator",
        "Dimension Vista\u2122 NT-proBNP (PBNP) Flex\u00ae reagent cartridge method",
        "Dimension Vista\u2122 NT-proBNP (PBNP) calibrator"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K061795",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032646",
        "K022516"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBC",
        "JIT"
    ],
    "Summary Letter Date": "September 11, 2006",
    "Summary Letter Received Date": "August 15, 2006",
    "Submission Date": "August 14, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1117"
    ],
    "Regulation Name(s)": [
        "B-type natriuretic peptide test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "N-terminal pro-brain natriuretic peptide (NT-proBNP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Luminescent Oxygen Channeling Immunoassay (LOCI\u2122)"
    ],
    "Methodologies": [
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent cartridge",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Dimension Vista\u2122 NT-proBNP (PBNP) Flex\u00ae reagent cartridge method and calibrator for quantitative measurement of NT-proBNP in serum and plasma.",
    "Indications for Use Summary": "In vitro diagnostic assay and calibrator for quantitative measurement of NT-proBNP in human serum and plasma to aid in diagnosis, assessment of severity, and risk stratification of congestive heart failure and acute coronary syndrome.",
    "fda_folder": "Clinical Chemistry"
}